Barclay Phillips
Director/Board Member presso IMMUNIC, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Barclay A.
Phillips is currently the Lead Independent Director at Immunic, Inc., a Member-Supervisory Board member at Immunic AG, and the Chief Operating & Financial Officer at Ribometrix, Inc. He previously held positions as Director-Private Placements at Invesco Advisers, Inc., Director-Private Placements at INVESCO Funds Group, Inc., Director at CancerVax Corp., Director at Acorda Therapeutics, Inc., Managing Director at Vector Fund Management LP, Managing Director at Vector Asset Management, Inc., Chief Financial Officer, Treasurer & Senior VP at Novavax, Inc., Principal at PaineWebber, Inc., General Partner at Apjohn Ventures LLC, Chief Financial Officer & Senior Vice President at Amgen Rockville, Inc., Principal at Shearson Lehman Hutton, Inc., and CFO & Senior VP-Corporate Development at G1 Therapeutics, Inc. He received his undergraduate degree from the University of Colorado Boulder.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMMUNIC, INC.
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Barclay Phillips
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNIC, INC. | Director/Board Member | 19/11/2019 |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Director/Board Member | - |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Director of Finance/CFO | 04/08/2020 |
Precedenti posizioni note di Barclay Phillips
| Società | Posizione | Fine |
|---|---|---|
| G1 THERAPEUTICS, INC. | Director of Finance/CFO | 10/05/2019 |
| NOVAVAX, INC. | Director of Finance/CFO | 10/11/2017 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Director of Finance/CFO | 29/07/2009 |
Vector Asset Management, Inc.
 Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Chief Investment Officer | 30/09/2008 |
Vector Fund Management LP
 Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Corporate Officer/Principal | 01/08/2008 |
Formazione di Barclay Phillips
| University of Colorado Boulder | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Invesco Advisers, Inc.
 Invesco Advisers, Inc. Investment ManagersFinance Invesco Advisers, Inc. is a SEC-registered investment advisor headquartered in Atlanta, Georgia. They are a subsidiary of Invesco Group Services, Inc., ultimately held by Invesco Ltd. (NYSE: IVZ). The firm was founded in 1986 and previously known as Invesco Institutional NA, Inc. until April 2010 when Invesco Ltd. consolidated the businesses of their US investment advisors (Invesco AIM Advisors, Inc., Invesco AIM Capital Management, Inc., Invesco AIM Private Asset Management, Inc. and Invesco Global Asset Management NA, Inc.) under the name Invesco Advisers, Inc. They provide discretionary and non-discretionary investment advisory services to individuals, institutional and high net-worth clients through separate accounts, wrap fee programs and US registered investment companies and other Commingled Funds. | Finance |
INVESCO Funds Group, Inc.
 INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a private company based in Denver, CO. | Finance |
| CancerVax Corp. | Commercial Services |
Vector Fund Management LP
Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Finance |
| PaineWebber, Inc. | Finance |
Apjohn Ventures LLC
 Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Finance |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
| Shearson Lehman Hutton, Inc. | Finance |
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Finance |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
- Borsa valori
- Insiders
- Barclay Phillips
